Pictet Asset Management Holding SA Boosts Holdings in Henry Schein, Inc. (NASDAQ:HSIC)

Pictet Asset Management Holding SA boosted its holdings in Henry Schein, Inc. (NASDAQ:HSIC - Free Report) by 8.9% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 77,848 shares of the company's stock after acquiring an additional 6,338 shares during the quarter. Pictet Asset Management Holding SA owned 0.06% of Henry Schein worth $5,387,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors have also added to or reduced their stakes in the company. Olstein Capital Management L.P. boosted its holdings in shares of Henry Schein by 17.2% during the 4th quarter. Olstein Capital Management L.P. now owns 109,000 shares of the company's stock valued at $7,543,000 after acquiring an additional 16,000 shares during the last quarter. Private Management Group Inc. boosted its holdings in Henry Schein by 5.7% in the fourth quarter. Private Management Group Inc. now owns 350,515 shares of the company's stock worth $24,256,000 after purchasing an additional 18,882 shares during the last quarter. Equitable Trust Co. bought a new stake in Henry Schein in the 4th quarter worth approximately $417,000. Savant Capital LLC grew its position in Henry Schein by 43.9% in the 4th quarter. Savant Capital LLC now owns 4,651 shares of the company's stock worth $322,000 after purchasing an additional 1,420 shares during the period. Finally, Mirae Asset Global Investments Co. Ltd. raised its stake in Henry Schein by 29.9% during the 4th quarter. Mirae Asset Global Investments Co. Ltd. now owns 15,854 shares of the company's stock valued at $1,113,000 after buying an additional 3,650 shares during the last quarter. 96.62% of the stock is owned by institutional investors.

Insider Transactions at Henry Schein

In other Henry Schein news, Director Philip A. Laskawy sold 2,604 shares of Henry Schein stock in a transaction that occurred on Wednesday, March 19th. The stock was sold at an average price of $71.04, for a total value of $184,988.16. Following the sale, the director now owns 24,805 shares of the company's stock, valued at $1,762,147.20. The trade was a 9.50 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through the SEC website. Also, CEO Bradford C. Connett sold 4,036 shares of the company's stock in a transaction that occurred on Wednesday, March 19th. The stock was sold at an average price of $71.15, for a total value of $287,161.40. Following the sale, the chief executive officer now directly owns 62,688 shares in the company, valued at $4,460,251.20. This trade represents a 6.05 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders own 1.14% of the company's stock.

Analysts Set New Price Targets

Several analysts recently commented on the company. Jefferies Financial Group lifted their price objective on Henry Schein from $77.00 to $80.00 and gave the stock a "hold" rating in a report on Thursday, January 23rd. Bank of America upgraded Henry Schein from an "underperform" rating to a "buy" rating and boosted their price target for the company from $69.00 to $84.00 in a research note on Monday, January 6th. Wells Fargo & Company started coverage on shares of Henry Schein in a research note on Friday, February 14th. They issued an "equal weight" rating and a $80.00 price objective on the stock. Barrington Research restated an "outperform" rating and set a $90.00 target price on shares of Henry Schein in a research report on Wednesday, February 26th. Finally, UBS Group decreased their price target on shares of Henry Schein from $83.00 to $80.00 and set a "neutral" rating on the stock in a research report on Wednesday, February 26th. Six analysts have rated the stock with a hold rating, five have issued a buy rating and one has given a strong buy rating to the company. Based on data from MarketBeat, the company has a consensus rating of "Moderate Buy" and a consensus target price of $81.10.

Henry Schein Price Performance

Henry Schein stock traded down $1.61 during mid-day trading on Tuesday, hitting $62.70. The stock had a trading volume of 1,847,194 shares, compared to its average volume of 1,593,191. Henry Schein, Inc. has a one year low of $61.86 and a one year high of $82.49. The company has a current ratio of 1.42, a quick ratio of 0.82 and a debt-to-equity ratio of 0.46. The firm has a market capitalization of $7.79 billion, a P/E ratio of 25.80, a P/E/G ratio of 2.13 and a beta of 0.84. The firm's 50 day moving average is $73.10 and its 200 day moving average is $72.40.

Henry Schein (NASDAQ:HSIC - Get Free Report) last released its earnings results on Tuesday, February 25th. The company reported $1.19 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.23 by ($0.04). Henry Schein had a return on equity of 12.90% and a net margin of 2.51%. The business had revenue of $3.19 billion for the quarter, compared to analysts' expectations of $3.25 billion. During the same quarter in the prior year, the business posted $0.66 EPS. The business's revenue for the quarter was up 5.8% compared to the same quarter last year. On average, sell-side analysts forecast that Henry Schein, Inc. will post 4.74 earnings per share for the current fiscal year.

Henry Schein Company Profile

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.